The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension

F. Reichenberger, R. Voswinckel, M. Thamm, F. Lendeckel, R. Schulz, M. Kappert, J. Dämming, R. Morty, C. Tanislav, H. A. Ghofrani, W. Seeger, H. Tiede (Giessen, München-Gauting, Germany)

Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Session: Pulmonary circulation: clinical end-points and clinical physiology
Session type: Thematic Poster Session
Number: 3933
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Reichenberger, R. Voswinckel, M. Thamm, F. Lendeckel, R. Schulz, M. Kappert, J. Dämming, R. Morty, C. Tanislav, H. A. Ghofrani, W. Seeger, H. Tiede (Giessen, München-Gauting, Germany). The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension. Eur Respir J 2012; 40: Suppl. 56, 3933

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The value of cardiopulmonary exercise test in assessment of the severity of pulmonary arterial hypertension patients
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017

Cardiopulmonary exercise testing in patients with severe pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 489s
Year: 2001

Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension
Source: Eur Respir J 2012; 40: 1410-1419
Year: 2012



Maximal cardiopulmonary exercise testing in children with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008


The role of cardiopulmonary exercise tests in pulmonary arterial hypertension
Source: Eur Respir Rev, 27 (148) 170134; 10.1183/16000617.0134-2017
Year: 2018



Value of maximal and submaximal variables during incremental cardiopulmonary exercise testing to predict survival in pateints with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009


Predictive value of combined metabolic and cardiopulmonary responses to estimate maximal aerobic impairment in patients with pulmonary arterial hypertension
Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy
Year: 2010

Cardiopulmonary exercise testing for detection of early pulmonary vascular changes in relatives of patients with idiopathic pulmonary arterial hypertension
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007




Comparison of three walking tests to cardiopulmonary exercise tests in the assessment of exercise tolerance in individuals with pulmonary arterial hypertension
Source: International Congress 2016 – Physiotherapy interventions and assessment options in hospitalised patients
Year: 2016

Cardiopulmonary exercise testing, six minute walk and hemodynamics in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008


Distinguishing pulmonary hypertension in interstitial lung disease by ventilation and perfusion defects as measured by cardiopulmonary exercise testing
Source: Annual Congress 2012 - Exercise testing in disease
Year: 2012


Exercise ventilatory inefficiency is an independent predictor of mortality in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012


Cardiopulmonary exercise test unveils abnormal exercise physiology in patients affected by pulmonary arterial hypertension with a low-risk profile 6 minute walk distance.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020


Early histological changes of pulmonary arterial hypertension disclosed by invasive cardiopulmonary exercise testing
Source: International Congress 2019 – CCC Pulmonary vascular diseases
Year: 2019



Gas exchange abnormality during cardiopulmonary exercise test in patients with primary pulmonary hypertension
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012

The role of cardiopulmonary exercise test in identifying pulmonary veno-occlusive disease
Source: Eur Respir J, 57 (6) 2100115; 10.1183/13993003.00115-2021
Year: 2021



Comparing cardiopulmonary responses to incremental exercise in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension
Source: Annual Congress 2011 - Altered mechanisms during exercise in disease
Year: 2011


Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005